The Dr. Goodenowe NeuroSupport Program is a community health initiative designed to provide advanced scientific education and a supportive network for families caring for children and adults with autism and those navigating related neurodevelopmental disorders. The program emphasizes learning, shared understanding, and community connection in a non-clinical, self-directed setting.*
Program Offerings & Value
In an effort to provide this support to families, Dr. Goodenowe has announced the launch of the NeuroSupport Program, offering the following to eligible participants:
- Core Support: A complimentary 3-month supply of Dr. Goodenowe’s proprietary plasmalogen precursor supplements, provided for educational and evaluation purposes only.
- Value: This represents a retail value of over $1,000 for each participating individual.
- Advanced Education: Access to specialized educational resources and training materials.
- Community & Networking: Integration into a robust network to encourage community connection, networking, and peer-to-peer engagement.
Enrollment Details
- Eligibility: Open to all families with an individual with autism or other neurodevelopmental conditions.
- Deadline: Enrollment closes on 1/31/26.
- Funding: The initial 3-month program is being donated by Dr. Goodenowe. Continuation will be subsidized through generous donations via our collaboration with Autism Health where we plan to expand the offering based on charitable support.
Interested in learning more and participating in this community-based initiative? Complete this online form to apply today.
*This program is a commercial offer and not a clinical trial. Families should consult their health care professionals.
Participation in the NeuroSupport Program is voluntary and self-directed. The program does not provide medical care, diagnosis, or treatment.
Disclaimer: The information presented is provided for general informational and educational purposes only. Products, services, or statements mentioned have not been evaluated by the U.S. Food and Drug Administration (FDA), Health Canada or any other regulatory authority unless explicitly stated otherwise. Nothing should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.
